Screener

Acquired in-process research and development

Name: Eli Lilly Acquired in-process research and development by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Eli Lilly·Business Segments·1 segment·Rolls up to Acquired in-process research and development

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	$1.57B	$154M	$655.7M	$528.8M	$584M	$2.78B
Total	$1.57B	$153.8M	$655.7M	$528.8M	$584M	—

Segments

Business SegmentsView metric